Modulation of yeast Erg1 expression and terbinafine susceptibility by iron bioavailability. Issue 11 (15th July 2022)
- Record Type:
- Journal Article
- Title:
- Modulation of yeast Erg1 expression and terbinafine susceptibility by iron bioavailability. Issue 11 (15th July 2022)
- Main Title:
- Modulation of yeast Erg1 expression and terbinafine susceptibility by iron bioavailability
- Authors:
- Jordá, Tania
Martínez‐Martín, Ana
Martínez‐Pastor, María Teresa
Puig, Sergi - Abstract:
- Abstract: Ergosterol is a specific sterol component of yeast and fungal membranes. Its biosynthesis is one of the most effective targets for antifungal treatments. However, the emergent resistance to multiple sterol‐based antifungal drugs emphasizes the need for new therapeutic approaches. The allylamine terbinafine, which selectively inhibits squalene epoxidase Erg1 within the ergosterol biosynthetic pathway, is mainly used to treat dermatomycoses, whereas its effectiveness in other fungal infections is limited. Given that ergosterol biosynthesis depends on iron as an essential cofactor, in this report, we used the yeast Saccharomyces cerevisiae to investigate how iron bioavailability influences Erg1 expression and terbinafine susceptibility. We observed that both chemical and genetic depletion of iron decrease ERG1 expression, leading to an increase in terbinafine susceptibility. Deletion of either ROX1 transcriptional repressor or CTH1 and CTH2 post‐transcriptional repressors of ERG1 expression led to an increase in Erg1 protein levels and terbinafine resistance. On the contrary, overexpression of CTH2 led to the opposite effect, lowering Erg1 levels and increasing terbinafine susceptibility. Although strain‐specific particularities exist, opportunistic pathogenic strains of S. cerevisiae displayed a response similar to the laboratory strain. These data indicate that iron bioavailability and particular regulatory factors could be used to modulate susceptibility toAbstract: Ergosterol is a specific sterol component of yeast and fungal membranes. Its biosynthesis is one of the most effective targets for antifungal treatments. However, the emergent resistance to multiple sterol‐based antifungal drugs emphasizes the need for new therapeutic approaches. The allylamine terbinafine, which selectively inhibits squalene epoxidase Erg1 within the ergosterol biosynthetic pathway, is mainly used to treat dermatomycoses, whereas its effectiveness in other fungal infections is limited. Given that ergosterol biosynthesis depends on iron as an essential cofactor, in this report, we used the yeast Saccharomyces cerevisiae to investigate how iron bioavailability influences Erg1 expression and terbinafine susceptibility. We observed that both chemical and genetic depletion of iron decrease ERG1 expression, leading to an increase in terbinafine susceptibility. Deletion of either ROX1 transcriptional repressor or CTH1 and CTH2 post‐transcriptional repressors of ERG1 expression led to an increase in Erg1 protein levels and terbinafine resistance. On the contrary, overexpression of CTH2 led to the opposite effect, lowering Erg1 levels and increasing terbinafine susceptibility. Although strain‐specific particularities exist, opportunistic pathogenic strains of S. cerevisiae displayed a response similar to the laboratory strain. These data indicate that iron bioavailability and particular regulatory factors could be used to modulate susceptibility to terbinafine. Abstract : Both chemical and genetic depletion of iron decrease Saccharomyces cerevisiae squalene epoxidase Erg1 expression, leading to an increase in terbinafine susceptibility. Deletion of either ROX1 transcriptional repressor or CTH1 and CTH2 post‐transcriptional repressors of ERG1 expression led to an increase in Erg1 protein levels and terbinafine resistance. Although strain‐specific particularities exist, opportunistic pathogenic strains of S. cerevisiae displayed a response similar to the laboratory strain. … (more)
- Is Part Of:
- Microbial biotechnology. Volume 15:Issue 11(2022)
- Journal:
- Microbial biotechnology
- Issue:
- Volume 15:Issue 11(2022)
- Issue Display:
- Volume 15, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 15
- Issue:
- 11
- Issue Sort Value:
- 2022-0015-0011-0000
- Page Start:
- 2705
- Page End:
- 2716
- Publication Date:
- 2022-07-15
- Subjects:
- Microbial biotechnology -- Periodicals
Biotechnology
Microbiology
660.62 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=714890 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1751-7915 ↗
http://www.blackwellpublishing.com/mbt_enhanced/aims.asp ↗
http://www3.interscience.wiley.com/journal/118902527/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1751-7915.14102 ↗
- Languages:
- English
- ISSNs:
- 1751-7915
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.911050
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24736.xml